MarketsandMarkets Real-World Evidence and Data Analytics Conference
RWDA, Germany:
The healthcare sector, which has relied on diverse clinical trials, medical literature, patient outcomes data, case studies, or treatment patterns, has struggled for decades to efficiently integrate and analyze this data consistently. With the recent data boom the sector is experiencing, this dilemma is getting more urgent. Real-world data (RWD), which focuses on the needs of the patient, is becoming more and more important in guiding medical policy. The monitoring of post-marketing medication safety and decision assistance in clinical practice are just two processes that RWD influences and informs. If analytics, machine learning, and artificial intelligence are used to fuel RWD, it will eventually transform into actionable real-world evidence (RWE), which could finally result in the right medicine being administered at the appropriate moment.
Here is a great opportunity for you to witness and network with real-world evidence and Life Sciences Analytics' latest innovations and research studies. Join us at our 6th Annual Markets and Markets Real-World Evidence and Life Sciences Analytics Conference, scheduled to be held on October 5–6, 2023, in Frankfurt, Germany. The major takeaway from this conference will be improved decision-making. It will be centered on the important aspects mentioned above and hold discussions on the best practices followed by various stakeholders. Register Now
The healthcare sector, which has relied on diverse clinical trials, medical literature, patient outcomes data, case studies, or treatment patterns, has struggled for decades to efficiently integrate and analyze this data consistently. With the recent data boom the sector is experiencing, this dilemma is getting more urgent. Real-world data (RWD), which focuses on the needs of the patient, is becoming more and more important in guiding medical policy. The monitoring of post-marketing medication safety and decision assistance in clinical practice are just two processes that RWD influences and informs. If analytics, machine learning, and artificial intelligence are used to fuel RWD, it will eventually transform into actionable real-world evidence (RWE), which could finally result in the right medicine being administered at the appropriate moment.
Here is a great opportunity for you to witness and network with real-world evidence and Life Sciences Analytics' latest innovations and research studies. Join us at our 6th Annual Markets and Markets Real-World Evidence and Life Sciences Analytics Conference, scheduled to be held on October 5–6, 2023, in Frankfurt, Germany. The major takeaway from this conference will be improved decision-making. It will be centered on the important aspects mentioned above and hold discussions on the best practices followed by various stakeholders. Register Now
